Delayed release of brain natriuretic peptide to identify myocardial ischaemia

Stephan Zürcher1,2, Ursina Honegger1,2, Max Wagener1,2

  • 1Department of Cardiology, University Hospital Basel, Basel, Switzerland.

Insights

Delayed cardiac biomarker sampling for exercise-induced myocardial ischemia showed no diagnostic benefit. B-type natriuretic peptide (BNP) levels were higher in patients with ischemia, but late sampling did not improve accuracy.

Area of Science:

  • Cardiology
  • Biomarker Research
  • Diagnostic Imaging

Background:

  • A prior pilot study suggested delayed cardiac biomarker release following exercise-induced myocardial ischemia.
  • This indicated potential for later sampling (e.g., 4 hours post-exercise) for diagnostic purposes.

Purpose of the Study:

  • To investigate if delayed sampling of B-type natriuretic peptide (BNP) improves diagnosis of myocardial ischemia.
  • To evaluate the diagnostic accuracy of BNP levels at rest, peak stress, and 4 hours post-stress.

Main Methods:

  • An observational study included 129 patients undergoing myocardial perfusion imaging for suspected coronary artery disease.
  • BNP levels were measured at rest, peak stress, and 4 hours post-stress.
  • Clinical judgment and imaging determined the presence of myocardial ischemia.

Main Results:

  • Myocardial ischemia was present in 45% of patients.
  • Patients with ischemia had significantly higher BNP levels at all measured time points (rest, peak, 4h).
  • Diagnostic accuracy (AUC) was moderate and similar across all time points (0.64-0.66); the change in BNP did not add value.

Conclusions:

  • Contrary to the hypothesis, myocardial ischemia did not result in differential delayed BNP release.
  • Late sampling of BNP (4 hours post-stress) did not appear clinically useful for diagnosing myocardial ischemia.
Abstract